Best free Kosmos (Edison Scientific / FutureHouse) alternatives
Looking for a free alternative to Kosmos (Edison Scientific / FutureHouse)? Here are 9 science & research ai worth trying — 9 with a free tier. Kosmos (Edison Scientific / FutureHouse) itself is free tier + paid.
What is the best free alternative to Kosmos (Edison Scientific / FutureHouse)?
AlphaFold Server is the closest free alternative to Kosmos (Edison Scientific / FutureHouse): same Science & Research AI sub-category, and it is free. Free browser-based access to AlphaFold 3-class structure prediction for non-commercial research
Are there free Kosmos (Edison Scientific / FutureHouse) alternatives?
Yes — 9 of the 9 alternatives listed here are free or freemium: AlphaFold Server, Boltz, Chai-1 (Chai Discovery), Scira, Morphic. None of them are paid-only.
Is Kosmos (Edison Scientific / FutureHouse) free?
Kosmos (Edison Scientific / FutureHouse) is free tier + paid. There is a free tier you can work in, with paid plans above it.
How were these Kosmos (Edison Scientific / FutureHouse) alternatives chosen?
They are the other tools in Science & Research AI, then the rest of Research & Learning, ordered free tiers first and capped at 9. There is no sponsorship and no paid placement in that ordering — only the pricing tier decides.
All Kosmos (Edison Scientific / FutureHouse) alternatives
✦ WhyA Kosmos (Edison Scientific / FutureHouse) alternative — First fully open-source model to approach AlphaFold3-level structure prediction, MIT-licensed.
First fully open-source model to approach AlphaFold3-level structure prediction, MIT-licensed
Boltz-2 adds binding-affinity prediction, not just structure
Hostable free via community web apps (e.g. Tamarind Bio) or run locally
✦ WhyA Kosmos (Edison Scientific / FutureHouse) alternative — Chai-1 is free, Apache-2.0-licensed for academic and commercial use — a genuinely open structure-prediction model.
Chai-1 is free, Apache-2.0-licensed for academic and commercial use — a genuinely open structure-prediction model
Chai-2 (paid, enterprise) generates de novo antibodies directly from target epitopes, used by Lilly, Novartis, Pfizer